Prophylactic Levofloxacin Use in Oncology and Hematopoietic Stem Cell Transplants for Children Under 2 Years of Age
{{output}}
This study evaluates the efficacy and safety of levofloxacin (LVX) prophylaxis against bacteremia and febrile neutropenia in infants under 6 months of age compared with those 6 months to 2 years old with acute myeloid leukemia (AML), relapsed acute lymphoblast... ...
